Ischemia Technologies


Ischemia Technologies, Inc. developed products and technologies to revolutionize the standard of care for patients with ischemia, based on its patented biochemical marker, in which a protein in blood appears to be modified when exposed to ischemic tissue. Ischemia occurs when there is an imbalance between oxygen supply and demand, and can lead to heart attack and stroke.

Ischemia Technologies was acquired by Inverness Medical Innovations (AMEX:IMA) in May 2006.